Figures & data
Table 1. Availability of assays.
Table 1. Pharmacokinetic parameters for paracetamol. Data are presented as mean [SD].
Table 1. The sensitivities and times to fulfillment of prognostic indicators in acetaminophen poisoning.
Table 1. Prescription stimulant exposures reported to poison centres from 2007–2010.
Table 1. Comparison of NPIS and NPDS enquiries
Table 1. Cardiac disorders in cyanide intoxication after smoke inhalation.
Table 1. APAP-CYSTEINE protein adduct levels in the patient*, in therapeutic acetaminophen dosing** and in acetaminophen overdose and toxicity1***.
Table 1. Forensic news in Turkish newspapers.
Table 1. Carisoprodol exposures and subsets.
Table 1. Mean number of calls/year and the percentage change over time of calls by Reasons.
Table 1. Prescription opioid exposure rates as reported by poison centres by country 2007–2010.
Table 1. Examples of unsuccessful user searches on TOXBASE® in October 2011.
Table 1. Signs and symptoms in paliperidone overdoses.
Table 1. Top 10 non-ocular products administered into the eye.
Table 1. ROC analysis of admission and 24 hour AUC values of RBC AChE, serum BuChE and serum chlorpyrifos levels in predicting the development of intermediate spectrum disorder.
Table 1. Percentage fall (±95%CI) in drug concentration in human plasma (ratio: ILE/control).
Table 1. Comparison of monthly accesses to pseudoephedrine, ephedrine and methamphetamine on TOXBASE®, March 2005 – December 2010.
Table 1. Frequency of lifetime and last month use amongst the men who have sex with men (MSM) and non-MSM respondents.
Table 1. Frequency of presentations for individual drugs per year from 2006 to 2010.
Table 1. Frequency of specific clinical effects for exposures to buprenorphine and methadone with and without benzodiazepines.
Table 1. Laboratory results for methanol poisonings.
Table 1. Patients characteristics, midodrine dose, signs and symptoms with classification according to severity (Poisoning Severity Score).